"Nolpaza": ntuziaka maka ojiji mbadamba maka gastric na duodenal ọnyá

"Nolpaza" - bụ hypoacid akụ nke na-emegide ọnyá afọ ọgwụ, ka otu ìgwè, ndị proton mgbapụta inhibitor. The ọgwụ na-eji maka mgbochi na ọgwụgwọ nke pathologies nke digestive tract. Ọgwụ "Nolpaza" analogues adị, dị ka "Panum", "Zipantola", "Kontrolok", "Peptazol", "Sanpraz", "Pantazi". All nke ha na-ekewet nke nọ n'ọrụ umi "pantoprazole", nke dose-ndabere na-adịgide adịgide utịp ke mgbochi nke gastric acid secretion.

The mejupụtara na ụdị "Nolpaza" ọgwụ

Guide na-akọ na 1 gastroresistant mbadamba ọgwụ "Nolpaza 20" ẹdude 20 mg pantaprazola. Na mbadamba nkume "Nolpaza 40" - 40 mg nke nọ n'ọrụ umi. Ọzọkwa e na Nwa adjuvants, gụnyere, na sorbitol.

Pharmacological ihe nke agwọ ọrịa "Nolpaza"

Guide akọ antiulcer ọgwụ Drugs - proton mgbapụta inhibitors (H + K + ATPase). The ọgwụ nwere ike ogologo oge suppression nke gastric acid secretion. The ọgwụ na-arụ ọrụ megide Helicobacter pylori na Helicobacter ike welie mmetụta nke ndị ọzọ ọgwụ ọjọọ.

Mgbe na-ewere ọgwụ "Nolpaza" ọgwụgwọ mmetụta dị mkpirikpi na-aga n'ihu ofụri usen. Mgbe igba ogwu n'akwara ntụtụ 80 mg ọgwụ antisecretory mmetụta esịmde a ọnụ ọgụgụ kasị elu n'oge abalị awa na-azọpụta, nke na-eme ka a ngwa ngwa ọnụ nke mgbaàmà na-agwọ ọrịa nke ọnyá na ndị duodenum. Ọ bụrụ na ingestion zuru ezu absorption nke na-aga ngwa ngwa. The ọgwụ nwere a obere n'ókè ike banye n'ime BBB, ọnụ na nzuzo dị na mmiri ara. Drug metabolism pụtara na imeju. The egosipụta ụdị metabolites, tumadi na mmamịrị, ifịm nwere ike achọpụtara obere obere. Ọ na-adịghị nwere ikike cumulating.

Egosi maka ọgwụ "Nolpaza"

Ntụziaka agụnye ojiji nke ọgwụ na:

- gastroesophageal reflux ọrịa nwayọọ;

- maka igbochi na ọgwụgwọ nke ọrịa na reflux esophagitis mgbe ọ bụla ogbo;

- ọgwụ ndị mmadụ na na gastric ma ọ bụ nsia peptic ọnyá afọ, na Zollinger-Ellison syndrome na ndị ọzọ ọnọdụ metụtara hypersecretion;

- iji gbochie ọnyá na ọrịa na-anata ogologo oge na-abụghị steroidal mgbochi mkpali ọgwụ ọjọọ.

"Nolpaza" The ọgwụ ike ga-ndinọ na kompleknoy ọgwụgwọ na antimicrobial ọgwụ ọjọọ na-egbu Helicobacter pylori.

Contraindications ọgwụ "Nolpaza"

Manual anaghị nwere ike ikwu iji na ọrịa na hypersensitivity, ịba ọcha n'anya na imeju nke imeju esonyere hepatic ọdịda bụ oké.

Emeli ka iji "Nolpaza" ọgwụ

- ọrịa nke imeju ọrụ,

- na nwata,

- Pregnancy, lactation.

mmetụta

Na digestive tract ime:

- afọ ọsịsa;

- akọrọ ọnụ,

- mụbara agụụ,

- ọgbụgbọ,

- belching,

- vomiting,

- flatulence,

- abdominal mgbu,

- ntachi,

- abawanye na transaminases,

- eriri afọ carcinoma.

Na ụjọ usoro na sensory akụkụ:

- isi ọwụwa;

- ike ọgwụgwụ, ajụ obubu, somnolence, ehighi ura;

- nchegbu, ịda mbà n'obi, tremor, paresthesia;

- photophobia, bịara ikiri ọhụụ, tinnitus.

Na urogenital usoro:

- hematuria,

- edema,

- enweghi ike.

Na akpụkpọ:

- alopecia

- otutu,

- exfoliative dermatitis,

- nfụkasị Jeremaya dị ka ọkụ ọkụ, urticaria, pruritus, angioedema.

Ndị ọzọ na-na ụdị:

- hyperglycemia, myalgia;

- fever, eosinophilia, hyperlipoproteinemia, hypercholesterolemia.

Mmekọrịta ndị ọzọ ọgwụ ọjọọ eme ihe

Na n'otu oge ngwa nke nkwadebe "Nolpaza" na ndị ọzọ ọgwụ ọjọọ eme ihe mbelata digestibility nke ketoconazole na ọgwụ ọjọọ ndị ọzọ na onye Onyenwe anyị + na-agbado absorption.

Ụzọ nke Iji

Mbadamba "Nolpaza" ingested 40 mg - 1 mbanye kwa ụbọchị, nke ụtụtụ. The kacha dose nke ọgwụ - ugboro abụọ.

Na ọgwụgwọ nke ọnyá ọnya mere site Helicobacter pylori, ọnụ iji regimens na clarithromycin na metronidazole.

ovadozu

Ọ dịghị nkọwa nke ihe mgbaàmà. Na ovadozu na-atụ aro na-ebu a na-akwado na symptomatic ọgwụ. Dialysis na nke a na-atụle na-adịghị ike.

adọ aka ná ntị

Tupu ọgwụgwọ dị mkpa ewepu ọnụnọ nke ajọ ọrịa nke na nkọlọ na afo. Ọ bụghị na-atụ aro a ga-eji ọrịa na-abụghị ọnyá dyspepsia etiology. Older ọrịa na gbasara akụrụ impairment adịghị atụ aro na-enye a dose ukwuu karịa 40 mg / ụbọchị. Ọ bụrụ na e siri hepatic impairment, na onunu ogwu kwesịrị ka a gbanwee site ịchịkwa larịị nke imeju enzymes.